Antitumor activity of the novel nitrosourea S10036 in rodent tumors.

Abstract

The activity of the novel anticancer agent diethyl 1-3-(chloroethyl)-3-nitrosoureido ethyl phosphonate (S10036) was investigated on several rodent tumors. S10036 showed a good efficacy, comparable to that of the anticancer agent BCNU, against i.p transplanted P388 and L1210 leukemias. S10036 was very effective against the primary tumor and metastases of i.m transplanted M5076 reticular cell sarcoma of the mouse and against subline A of the Walker carcinoma of the rat. It was inactive against rodent tumors resistant to BCNU such as L1210/BCNU, ICIG-Ci4 murine fibrosarcoma and the Walker carcinoma subline B in the rat.

• Authors: S Filippeschi, T Colombo, D Bassani, L De Francesco, P Arioli, M D'Incalci, I Bartosek, A Guaitani
• Journal: Anticancer research (Anticancer Res) 1988 Nov-Dec Vol. 8 Issue 6 Pg. 1351-4 ISSN: 0250-7005 [Print] Greece
• PMID: 3064716 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Nitrosourea Compounds
• Organophosphorus Compounds
• fotemustine

Topics

• Animals
• Antineoplastic Agents (therapeutic use)
• Carcinoma 256, Walker (drug therapy)
• Drug Evaluation, Preclinical
• Female
• Fibrosarcoma (drug therapy)
• Leukemia L1210 (drug therapy)
• Leukemia P388 (drug therapy)
• Lymphoma, Large B-Cell, Diffuse (drug therapy)
• Male
• Mice
• Mice, Inbred C57BL
• Mice, Inbred Strains
• Nitrosourea Compounds (therapeutic use)
• Organophosphorus Compounds (therapeutic use)
• Rats
• Rats, Inbred Strains